Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Tower Corp (AMT) vs Centene Corp (CNC) Price & Performance

American Tower CorpTrade
Centene CorpTrade

Price performance (Past 24H)

Key statistics

American Tower Corp vs Centene Corp — how do they compare? American Tower Corp trades at $169.49 (market cap $79.00B), while Centene Corp trades at $65.13 (market cap $32.05B). The key difference: American Tower Corp is far larger — about 2.5× Centene Corp's market cap, and American Tower Corp pays a 4.12% dividend while Centene Corp pays none. Which is the better fit depends on your goals.

AMTCNC
Market Cap
$79.00B$32.05B
Sector
Real EstateHealth
52-Week High
$211.88$68.72
52-Week Low
$162.11$26.17
Enterprise Value
$122.53B$21.10B
Dividend Yield
4.12%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American Tower Corp

American Tower owns and operates more than 220,000 cell towers throughout the U.S., Asia, Latin America, Europe, and Africa. It also owns and/or operates 25 data centers in eight U.S. markets after acquiring CoreSite. On its towers, the company has a very concentrated customer base, with most revenue in each market being generated by just the top few mobile carriers. The company operates more than 40,000 towers in the U.S., which accounted for more than half of its total revenue in 2021. Outside the U.S., American Tower's greatest presence is in India and Brazil, where it operates roughly 75,000 and 19,000 towers, respectively. American Tower operates as a real estate investment trust.

Read more on AMT

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC